What we know

In 2025, Stanford PhD student Samuel King used a generative AI model to design new viruses, demonstrating that artificial intelligence can create novel life forms. This development was discussed in the event "Roundtables: A Conversation With the Creator of AI-Designed Viruses," which highlighted both the technical achievements and the potential risks of AI in synthetic biology. Samuel King applied generative AI to design viruses in 2025. AI has shown the capability to create new biological entities.

Why it matters

The use of AI to design viruses marks a significant advance in synthetic biology, opening new possibilities for research and biotechnology. However, it also raises important ethical, safety, and security concerns about the potential misuse of AI-generated biological agents. Understanding these implications is crucial as AI-driven biological design continues to evolve.

What is still unknown

Details about the accuracy of the AI-designed viruses, the specific AI models and languages used, and any plans for broader deployment or regulation remain unclear. No independent evaluations of the technology’s effectiveness or safety have been reported.